| Filed On | Filing |
|---|---|
| 27 Aug 2025 |
Form 3: Karnawat Sunil Ratilal, Chief Commercial Officer
Holds 2,442 shares of Common Shares |
| 26 Mar 2025 |
Form 3: Harris Erik, Director
No securities owned |
| 25 Jan 2024 |
Form 3: Evans Daron, CFO
Holds 29,000 shares of Common Shares |
| 28 Jul 2021 | Form 3: Genexine Inc., 10% owner |
| 08 Mar 2021 |
Form 3: Hogenhuis Wladimir, Director
No securities owned |
| 08 Mar 2021 |
Form 3: Kreher Nerissa, Director
No securities owned |
| 30 Oct 2020 | Form 3: Roberts Brian Kenneth, Sr VP, Clinic Development |
| 16 Sep 2020 |
Form 3: Fauchet Philippe, Director
No securities owned |
| 31 Mar 2020 | Form 3: HANDOK, Inc., 10% owner |
| 09 Dec 2019 |
Form 3: Lim Junghee, Director
No securities owned |
| 27 Nov 2019 |
Form 3: Labrucherie Gil M, Director
Holds 47,042 shares of Common Shares |
| 11 Mar 2019 |
Form 3: Kim Young-Jin, Director
Holds 1,250,000 shares of Series AA Preferred Shares |
| 08 Mar 2019 |
Form 3: Sung Young Chul, Director
Holds 1,250,000 shares of Series AA Preferred Shares |
| 07 Mar 2019 |
Form 3: Miller Seline E., VP Finance & CAO
No securities owned |
| 17 May 2018 |
Form 3: Vendola Keith A., Chief Financial Officer
No securities owned |
| 30 Apr 2018 |
Form 3: Xoma Corp, 10% owner
Holds 8,093,010 shares of Common Stock |
| 29 Jun 2015 |
Form 3: Welch David F, Director
Holds 1,766,432 shares of Common Stock |
| 10 Sep 2014 |
Form 3: Dockery Carl, See remarks and 2 others
Holds 1,057,693.084 shares of Common Stock |
| 25 Jul 2014 | Form 3: Sherman Barry Michael, Director |
| 24 Jul 2014 | Form 3: Fields Morgan, Chief Accounting Officer |
Loading...